Novo Holdings, the investment firm behind pharmaceutical giant Novo Nordisk, is committing $25 million over five years to a new, early-stage biotech incubator at the Broad Institute, a research center affiliated with both Harvard and MIT.
The investment firm behind pharmaceutical giant Novo Nordisk is committing $25 million over five years to a new biotech incubator at the Broad Institute.
We are excited to partner with Novo Holdings on the Novo Broad Greenhouse! The new incubator will back approximately ten new research projects or companies at a time.
Novo Nordisk’s parent company to launch research incubator in Boston